Back
Ideal Power 10K Form
Sell
40
IPWR
Ideal Power
Last Price:
7.76
Seasonality Move:
7.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-15 | 10Q | IPWR/Ideal Power Quarterly |
| 2023-11-14 | 10Q | IPWR/Ideal Power Quarterly |
| 2023-08-11 | 10Q | IPWR/Ideal Power Quarterly |
| 2023-05-12 | 10Q | IPWR/Ideal Power Quarterly |
| 2022-11-14 | 10Q | IPWR/Ideal Power Quarterly |
| 2022-08-15 | 10Q | IPWR/Ideal Power Quarterly |
Receive IPWR News And Ratings
See the #1 stock for the next 7 days that we like better than IPWR
IPWR Financial Statistics
Sales & Book Value
| Annual Sales: | $198.87K |
|---|---|
| Cash Flow: | $-2.23M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.79 |
| Price / Book: | 2.78 |
Profitability
| EPS (TTM): | -1.53000 |
|---|---|
| Net Income (TTM): | $-10.28M |
| Gross Margin: | $38.26K |
| Return on Equity: | -64.4% |
| Return on Assets: | -56.85% |
Ideal Power Earnings Forecast
Key Ideal Power Financial Ratios
- The Gross Profit Margin over the past 13 years for IPWR is 19.24%.
- The Selling, General & Administrative Expenses for IPWR have been equal to 2,336.77% of Gross Profit Margin.
- The Research & Development expenses have been 2,887.92% of Revenue.
- The Interest Expense is -0.21% of Operating Income.
- The Net Earning history of IPWR is -5,005.29% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 7 years.
Ideal Power Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Electrical Equipment |
| Sector: | Industrials |
| Current Symbol: | IPWR |
| CUSIP: | 451622 |
| Website: | idealpower.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 23.26 |
| Quick Ratio: | 22.81 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IPWR Technical Analysis vs Fundamental Analysis
Sell
40
Ideal Power (IPWR)
is a Sell
Is Ideal Power a Buy or a Sell?
-
Ideal Power stock is rated a Sell
The current Ideal Power [IPWR] share price is $7.77. The Score for IPWR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.